A5072183243- HER2/EGFR in Cancer Research
- Advanced Breast Cancer Therapies
- Cancer Treatment and Pharmacology
- Competitive and Knowledge Intelligence
- PI3K/AKT/mTOR signaling in cancer
- MicroRNA in disease regulation
- Qualitative Comparative Analysis Research
- Breast Cancer Treatment Studies
- Immune cells in cancer
- Chemokine receptors and signaling
- Hormonal and reproductive studies
- Cancer-related molecular mechanisms research
- Big Data and Business Intelligence
- Antioxidant Activity and Oxidative Stress
- Circular RNAs in diseases
- Glycosylation and Glycoproteins Research
- Menopause: Health Impacts and Treatments
Henan University of Science and Technology
2019-2025
Nanchang University
2018-2025
Third Hospital of Nanchang
2018-2023
Increased expression of CCL18 has been observed in various malignancies and the urine samples patients with bladder cancer (BC). However, roles development, progression metastasis BC remain unclear. The present study demonstrated that was significantly associated advanced clinical stages BC. Furthermore, exogenous promoted cell invasion migration, induced epithelial‑mesenchymal transition (EMT) cells. Western blotting E‑cadherin, an epithelial marker, decreased, whereas matrix...
Pyrotinib (PYR) is a pan-HER kinase inhibitor that inhibits signaling via the RAS/RAF/MEK/MAPK and PI3K/AKT pathways. In this study, we aimed to investigate antitumor efficacy of pyrotinib combined with adriamycin (ADM) explore its mechanisms on HER2+ breast cancer. We investigated effects PYR ADM cancer in vitro vivo. MTT assay, Wound-healing, transwell invasion assays were used determine PYR, or cell proliferation, migration, SK-BR-3 AU565 cells vitro. Cell apoptosis cycle detected through...
Lutein, zeaxanthin, and β-cryptoxanthin are polar oxygenated carotenoids found to be detectable in more than 95% of the population United States. Research has linked these with lower coronary heart disease prevalence. This study investigates association serum lutein/zeaxanthin erectile dysfunction (ED) among middle-aged older men Serum were independent variables. The outcome variable was ED. Analyzed data from 1,302 (≥40 years old) who participated National Health Nutrition Examination...